ArticleJournal of clinical neurology (Seoul, Korea)2025

Safety and Tolerability of Wharton's Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study.

Jiwon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.